Journal
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
Volume 13, Issue -, Pages 197-200Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.jgar.2018.04.017
Keywords
Escherichia coli; Klebsiella pneumoniae; gyrA; parC; Plasmid-mediated quinolone resistance; PMQR genes
Categories
Funding
- Yasuj University of Medical Sciences (Yasuj, Iran)
Ask authors/readers for more resources
Objectives: Fluoroquinolones (FQs) are recommended as the drugs of choice for the empirical treatment of urinary tract infections (UTIs). This study investigated the molecular determinants of FQ resistance in Escherichia coli and Klebsiella pneumoniae isolates in Iran. Methods: A total of 364 clinical isolates of E. coli (n = 144) and K. pneumoniae (n = 220) were collected from patients with UTI. Susceptibility of the isolates to ciprofloxacin, levofloxacin, gatifloxacin and nalidixic acid was evaluated by disk diffusion. The presence of qnrA, qnrB and qnrS genes was assessed by PCR. Nucleotide sequences of the gyrA and parC genes were determined. Results: Eighty-seven (60.4%) and 15 (6.8%) E. coli and K. pneumoniae isolates, respectively, were resistant to at least one of the tested FQs. Plasmid-mediated quinolone resistance (PMQR) genes were detected in 12.6% and 60.0% of FQ-resistant E. coli and K. pneumoniae, respectively. Whilst qnrB predominated in K. pneumoniae, qnrS was the most prevalent PMQR gene in E. coli. S83L (98.9%) and D87N (59.8%) were the most frequent mutations identified in GyrA of E. coli, and 55.2% (n = 48) of FQ-resistant E. coli isolates had mutation in ParC harbouring S801 and E84V substitutions. The GyrAS83L substitution was found in only one FQ-resistant K. pneumoniae isolate. Conclusions: FQ resistance was much more common in E. coli isolates than in K. pneumoniae. Whilst mutations in the drug target-encoding genes gyrA and parC were the major mechanisms involved in FQ resistance in E. coli, PMQR determinants commonly mediated FQ resistance in K. pneumoniae. (C) 2018 Published by Elsevier Ltd on behalf of International Society for Chemotherapy of Infection and Cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available